Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 78 clinical trials
Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT

imaging (DWI) pulse sequence to identify more accurately recurrent tumors as well as early non-responders to therapy.

chemotherapy regimen
squamous cell carcinoma
pet-ct scan
  • 0 views
  • 15 Sep, 2021
  • 1 location
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

The aim of this study is to investigate whether inhibition of serum prolactin levels below normal range during cabergoline administration may reduce the recurrence rate after drug withdrawal in patients with prolactinomas.

prolactin
drug withdrawal
prolactinoma
cabergoline
  • 90 views
  • 27 Feb, 2022
  • 1 location
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

This phase II/IIII trial studies how well haloperidol and lorazepam work in controlling symptoms of persistent agitated delirium in patients with cancer that has spread to other places in the body undergoing palliative care. Haloperidol and lorazepam may help in controlling symptoms of agitated delirium in patients with cancer and …

lorazepam
haloperidol
agitation
cancer
palliative care
  • 3 views
  • 09 Feb, 2022
  • 2 locations
Trial of XRD-0394 a Kinase Inhibitor in Combination With Palliative Radiotherapy in Advanced Cancer Patients

recurrent cancer. The pharmacokinetic (PK) profile and pharmacodynamic (PD) effects of single-dose XRD-0394 administered in combination with palliative RT will also be characterized.

cancer
  • 2 views
  • 07 Oct, 2021
  • 2 locations
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

This is a phase 2 study that will assess the investigational drug, cabozantinib, in patients with liver cancer (specifically hepatocellular carcinoma) and who had received a liver transplant as a part of curative care, but the cancer has come back (recurred). The purpose of this study is to see how …

sorafenib
tyrosine
RET
liver transplant
cabozantinib
  • 0 views
  • 18 Apr, 2021
  • 1 location
Pembrolizumab, Ibrutinib and Rituximab in PCNSL

This research study is evaluating a combination therapy of 3 drugs as possible treatments for recurrent primary central nervous system lymphoma (PCNSL). The three drugs being used in the study are: Pembrolizumab (MK3475) Ibrutinib Rituximab (or biosimilar)

follicle stimulating hormone
ibrutinib
aptt
oophorectomy
hormonal contraception
  • 0 views
  • 29 May, 2022
  • 1 location
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

detection and treatment of recurrent disease for these highly specific pediatric patients with recurrent tumors.

  • 0 views
  • 25 Apr, 2022
  • 1 location
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

with recurrent tumors and a prior history of low- or intermediate-risk NMIBC tumors. Participants will receive pemigatinib for 4-6 weeks prior to standard of care transurethral resection of bladder

growth factor
bladder carcinoma
carcinoma
bladder cancer
invasive bladder cancer
  • 48 views
  • 19 Feb, 2022
  • 1 location
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer

This phase I trial studies the side effects and best dose of vandetanib and everolimus when given together in treating patients with cancer that has spread to other places in the body. Vandetanib and everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for …

metastasis
cancer
neutrophil count
absolute neutrophil count
palliative radiation therapy
  • 0 views
  • 28 Jun, 2021
  • 1 location
Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers

The purpose of this research study is to see how safe and tolerable, and to find the highest or best dose, of an investigational combination of drugs called enasidenib and venetoclax, in patients with relapsed (the cancer has come back) or refractory (the cancer does not respond or have stopped …

induction chemotherapy
IDH2
enasidenib
lymphoma
cancer
  • 0 views
  • 06 Dec, 2021
  • 2 locations